Global financing for health policy and systems research: a review of funding opportunities.

Health policy and systems research (HPSR) donor priorities global health financing health systems

Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
16 Mar 2023
Historique:
received: 30 06 2022
revised: 21 11 2022
accepted: 19 12 2022
pubmed: 23 12 2022
medline: 22 3 2023
entrez: 22 12 2022
Statut: ppublish

Résumé

Health policy and systems research (HPSR) is a neglected area in global health financing. Despite repeated calls for greater investment, it seems that there has been little growth. We analysed trends in reported funding and activity between 2015 and 2021 using a novel real-time source of global health data, the Devex.com database, the world's largest source of funding opportunities related to international development. We performed a systematic search of the Devex.com database for HPSR-related terms with a focus on low- and middle-income countries. We included 'programs', 'tenders & grants' and 'contract awards', covering all call statuses (open, closed or forecast). Such funding opportunities were included if they were related specifically to HPSR funding or had an HPSR component; pure biomedical funding was excluded. Our findings reveal a relative neglect of HPSR, as only ∼2% of all global health funding calls included a discernible HPSR component. Despite increases in funding calls until 2019, this situation reversed in 2020, likely reflecting the redirection of resources to rapid assessments of the impacts of the coronavirus disease 2019 (COVID-19) pandemic. Most identified projects represented small-scale opportunities-commonly for consultancies or technical assistance. To the extent that new data were generated, these projects were either tied to a specific large intervention or were narrow in scope to meet a specific challenge-with many examples informing policy responses to the Covid-19 pandemic. Nearly half of advertised funding opportunities were multi-country projects, usually addressing global policy priorities like health systems strengthening or development of coordinated public health policies at a regional level. The Covid-19 pandemic has shown why investing in HPSR is more important than ever to enable the delivery of effective health interventions and avoid costly implementation failures. The evidence presented here highlights the need to scale up efforts to convince global health funders to institutionalize the inclusion of HPSR components in all funding calls.

Identifiants

pubmed: 36546732
pii: 6956280
doi: 10.1093/heapol/czac109
pmc: PMC10019567
doi:

Types de publication

Review Journal Article

Langues

eng

Pagination

409-416

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Alliance for Health Policy and Systems Research

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.

Auteurs

Alexander Kentikelenis (A)

Department of Social and Political Sciences, Bocconi University, via Roentgen 1, Milan 20136, Italy.

Abdul Ghaffar (A)

Alliance for Health Policy and Systems Research, World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.

Martin McKee (M)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Livia Dal Zennaro (L)

Alliance for Health Policy and Systems Research, World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.

David Stuckler (D)

Department of Social and Political Sciences, Bocconi University, via Roentgen 1, Milan 20136, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH